Hong Kong Pharmacy Digital Technology (HKPD.US) IPO priced at $4/share, raising $6 million.

Hong Kong Pharma Digital Technology, a company that offers cross-border supply chain and distribution services for over-the-counter (OTC) drugs in China's mainland, priced its initial public offering (IPO) at $4 per share, at the lower end of the $4-$6 price range. The company will issue 1.4 million shares to raise $6 million. It will be listed on the Nasdaq under the ticker "HKPD".

The company's business mainly consists of two categories: cross-border supply chain services for OTC drugs and cross-border procurement and distribution of OTC drugs. Through cooperation with OTC drug suppliers, logistics companies, and merchants operating stores on e-commerce platforms in China, the company provides a one-stop solution for Chinese mainland customers who wish to purchase OTC drugs outside of China. Its services include pre-consultation, product information review, and procurement of overseas OTC drugs. The company's 12-month revenue as of March 31, 2024, was $17 million.